Respiratory Care Devices Market

The global Respiratory Care Devices Market is valued at USD 23.93 Billion in 2024 and is projected to reach a value of USD 54.38 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of 7.75% between 2025 and 2035.

Respiratory care devices comprise a broad spectrum of medical tools designed to assist in managing and treating respiratory disorders. These devices provide activities like oxygen therapy, breathing support, airway clearance, and respiratory health monitoring. In hospitals, homes, and emergency circumstances, they are crucial for providing respiratory assistance. They range from simple devices like oxygen masks and nasal cannulas to more complex ones like ventilators and CPAP machines. Through facilitating breathing, preserving oxygen saturation, and improving lung function, these devices aid in symptom relief, patient comfort, and the advancement of respiratory health outcomes.

The growth of Respiratory Care Devices market is primarily fueled by the increasing prevalence of respiratory disorders like COPD and asthma, a rising overweight and obese population, and a growing number of preterm births. Over the past two decades, preterm births have surged globally, often linked to pregnancies at high-risk ages, such as under 20 or over 40 years. The Respiratory Care Devices market is driven by maternal health conditions like diabetes, high blood pressure, and the extensive use of infertility therapies. Furthermore, some ethnic groups are genetically more likely to have preterm deliveries than others, such as African-American and Hispanic women in the United States.

Key Highlights

• In 2024, based on the Product, the Therapeutic Respiratory Care Devices category accounted for significant market share of 58.5%
• Based on the Disease Indication, the Chronic Obstructive Pulmonary Disease (COPD) category accounted for significant market share in 2024
• By End User, Hospitals segment dominated the Respiratory Care Devices market in 2024 with significant market share
• North America dominated the Respiratory Care Devices market with 42.3% market share in 2024
• Asia Pacific region is anticipated to grow at the highest CAGR during the forecast period

Product Overview

​The Product segment is divided into Therapeutic Respiratory Care Devices, Monitoring Devices, Diagnostic Respiratory Care Devices, Consumables & Accessories. The Therapeutic Respiratory Care Devices segment held the largest share of 58.5% in the Respiratory Care Devices market.

Therapeutic Respiratory Care Devices segment dominated the market including devices designed for the management and treatment of various respiratory conditions, such as chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea. The high market share is driven by the growing prevalence of respiratory diseases, increasing patient awareness, and advancements in technology that enhance the effectiveness and convenience of therapeutic devices.

The ICU ventilators segment held the largest share of the respiratory care devices market. The market is categorized by type into ICU ventilators and portable/transportable ventilators. In 2022, the ICU ventilators segment dominated the market. Increased ICU admissions and readmissions in industrialized nations, a favorable reimbursement environment, and the growing number of intensive care units with ventilators are some of the causes driving this trend.

Disease Indication Overview

​The Disease Indication segment is divided into  Chronic Obstructive Pulmonary Disease (COPD), Sleep Apnea, Asthma, Infectious Diseases, Other Disease Indications. The Chronic Obstructive Pulmonary Disease (COPD) segment held the dominant share in 2024, accounting for significant market share.

Chronic Obstructive Pulmonary Disease (COPD) dominated the market in 2024. Tobacco smoking is a primary cause of COPD, with the US Centers for Disease Control and Prevention (CDC) reporting that 8 out of 10 COPD-related deaths are attributed to smoking. Additionally, increasing levels of indoor and outdoor air pollution, along with exposure to dust and chemicals, are contributing to the growing prevalence of COPD.

End User

The End User segment is divided into Hospitals, Home Care Settings, Ambulatory Care Centers (ACCs), Other End Users. The Hospitals segment held the largest share in the Respiratory Care Devices market.

In 2024, the hospital segment led the market, driven by the increasing number of patient admissions to hospitals and ambulatory surgery centers (ASCs) for the treatment of sleep apnea, asthma, and other respiratory conditions. Furthermore, the expansion of hospitals and ASCs is expected to further fuel the growth of this segment. For example, according to 2023 data from ABOVE & BEYOND THERAPY, there are currently 7,335 active hospitals in the U.S.

The home care settings and other segment is also projected to grow during the forecast period. This growth is mainly due to the rise in product launches designed for home use and the increasing number of home care facilities and other settings providing diagnosis and treatment for respiratory disorders. For instance, in November 2023, Cipla, Inc. introduced Spirofy, a portable, wireless spirometer that patients can use at home to diagnose respiratory issues. As more home care respiratory products are launched, their adoption is expected to grow, further driving the market expansion.

Regional Overview

In 2024, the North America captured 42.3% of the revenue share.

North America Respiratory Care Devices market is driven by its advanced healthcare systems, high levels of patient awareness, and a growing elderly population prone to respiratory conditions. Furthermore, increased investments in research and development, leading to technological innovations and the adoption of cutting-edge respiratory solutions, are fueling market growth. The growing demand for therapeutic, diagnostic, and monitoring devices, as well as an increasing number of key players seeking regulatory approval for respiratory care devices products. Additionally, healthcare organizations in the region are ramping up strategic initiatives to raise awareness about the advantages of advanced technologies, further fueling market growth. For example, in November 2023, Vivos received U.S. FDA approval for its Vivos CARE oral appliance, designed to treat obstructive sleep apnea.

Europe Respiratory Care Devices Market

Europe is anticipated to experience growth due to the rising prevalence of Chronic Obstructive Pulmonary Disease (COPD), asthma, and other respiratory conditions, which is leading to higher patient admissions. This surge in cases is expected to drive demand for respiratory devices and boost their adoption. According to 2024 data from Asthma + Lung UK, approximately 5.4 million people in the UK are living with asthma, contributing to the rising demand for these devices.

Germany Respiratory Care Devices Market

Germany's Respiratory Care Devices market held a significant share in 2024, due to increasing prevalent chronic diseases.For instance, according to a July 2022 report in the Journal of Asthma and Allergy, asthma is one of the most prevalent chronic diseases in Germany, affecting approximately 4-5% of adults and 10% of children annually.

Asia Pacific Respiratory Care Devices Market

The Asia Pacific Respiratory Care Devices market is set for significant growth, driven by a rising geriatric population affected by asthma, infectious diseases, and other health conditions, thereby increasing demand for technologically advanced devices. Additionally, key players are focusing on mergers and collaborations to expand their market presence. For example, according to 2023 data from the Chinese government, about 297 million people are aged 60 and above in the country, a demographic that is likely to boost the demand for respiratory devices.

Latin America and Middle East & Africa Respiratory Care Devices Market

Latin America and the Middle East & Africa are expected to see growth during the forecast period as well, with rising rates of respiratory diseases in countries like Brazil, Mexico, the UAE, and others. Strategic initiatives by healthcare organizations in these regions are increasing awareness about the benefits of respiratory care devices.

Based on the provided market data, Vantage Market Research offers customizations in the reports to meet the specific needs of clients.

Key Trends

• Rising Adoption of Home Healthcare Devices: Growing preference for portable and home-based respiratory care devices due to convenience and cost-effectiveness is shaping the market
• Technological Advancements: Integration of AI, IoT, and advanced monitoring features in respiratory devices enhances patient outcomes and device efficiency
• Increased Demand Due to Respiratory Disorders: The rising prevalence of conditions like COPD, asthma, and sleep apnea is driving the need for innovative respiratory care solutions
• Expansion in Emerging Markets: Improved healthcare infrastructure and increased awareness in developing regions present significant growth opportunities
• Focus on Non-Invasive Ventilation (NIV): Non-invasive solutions are gaining traction due to their effectiveness, comfort, and reduced risk of infection
• Sustainability Initiatives: Manufacturers are prioritizing eco-friendly designs and reusable components in respiratory devices to address environmental concerns

‹›

Report Coverage & Deliverables

PDF report & online dashboard will help you understand:

• Real-Time Data Updates:
• Competitor Benchmarking
• Market Trends Heatmap
• Custom Research Queries
• Market Sentiment Analysis
• Demographic and Geographic Insights

Book Demo

Get Access Now

Track market trends LIVE & outsmart rivals with our Premium Data Intel Tool: Vantage Point

Key Sources

• European Medicines Agency (EMA)
• World Allergy Organization (WAO)
• American Lung Association (ALA)
• International COPD Coalition (ICC)
• Centers for Medicare & Medicaid Services (CMS)
• Centers for Disease Control and Prevention (CDC)
• Food and Drug Administration (FDA)
• National Institutes of Health (NIH)
• National Health Service (NHS)
• World Health Organization (WHO)
• National Center for Biotechnology and Information (NCBI)
• Government of Canada's Health and Wellness
• Australian Government Department of Health and Aged Care
• Ministry of Health and Family Welfare (MoHFW)
• National Health Mission (NHM)

Market Dynamics

Increasing Respiratory Disease Prevalence

Chronic obstructive pulmonary disease (COPD) is often caused by long-term asthma, tobacco smoke, air pollution, and exposure to occupational fumes and dust. Comorbidities such as cardiovascular issues, musculoskeletal impairments, and diabetes also complicate COPD management and affect patient outcomes. According to the WHO, approximately 262 million people suffered from asthma in 2019, resulting in 0.5 million deaths. Despite advancements, asthma morbidity and mortality remain critical challenges, with no treatment achieving complete disease normalization. By 2025, an additional 100 million asthmatic patients are expected globally. In the US, 1 in 12 people has asthma, while Europe has around 10 million individuals over 45 years old with the condition. Alarmingly, up to 1,000 asthma-related deaths occur daily.

Inadequate Reimbursement Policies

The lack of adequate reimbursements for diagnostic tests hinders patient access to respiratory care. The Centers for Medicare & Medicaid Services (CMS) 2020 Medicare Physician Fee Schedule introduced minor payment adjustments for sleep diagnostics. Rates for CPT 95800 tests, covering heart rate, oxygen saturation, and respiratory analysis, saw a 2% decline, while payments for CPT 95806 tests, including sleep and respiratory effort recordings, dropped by 15%. Such reductions discourage widespread adoption and add financial strain, particularly for uninsured or underinsured patients.

Growth in Point-of-Care (POC) Diagnostics

Point-of-care testing near patient care sites offers significant opportunities for respiratory diagnostics. Enhanced test accuracy and rising demand for diagnostics support POC market expansion. Technological advancements, such as device miniaturization and microfabrication, facilitate easier disease management. Governments globally are recognizing the potential of POC technologies in strengthening healthcare systems and addressing unmet patient needs. Furthermore, the shortage of skilled technicians in centralized labs increases the demand for decentralized POC solutions, empowering patients through self-testing and better disease management.

Poor Patient Compliance

Low compliance with CPAP therapy presents a major hurdle for market growth. Affordability and discomfort often deter patients from adhering to treatments. Insufficient reimbursements in regions like Asia and parts of the Rest of the World exacerbate this issue. Studies reveal that 30-50% of patients struggle to continue CPAP therapy due to the claustrophobic nature of the equipment. Additionally, surveys indicate that nearly half of CPAP users discontinue treatment within the first 1-3 weeks, primarily due to mask discomfort and airflow irritation, highlighting the need for more patient-friendly solutions.

Competitive Landscape

The Respiratory Care Devices market is characterized by the presence of leading players such as Philips Healthcare, ResMed Inc., Fisher & Paykel Healthcare, Medtronic, and Vyaire Medical, alongside several emerging companies. Key players are focusing on product innovation, strategic partnerships, and acquisitions to strengthen their market position. Advances in portable and home-based respiratory devices, increasing prevalence of respiratory disorders, and technological developments drive intense competition, fostering market growth.

The key players in the global Respiratory Care Devices market include - Masimo, Drägerwerk AG & Co. KGaA, Hamilton Medical, Becton, Dickinson and Company, Invacare Corporation, Chart Industries, Koninklijke Philips N.V., ResMed, Fisher & Paykel Healthcare Limited, Medtronic. among others.

Recent Market Developments

Medline Industries Expands Product Portfolio with Launch of Hudson RCI TurboMist Nebulizer

• May 2024: Medline Industries, Inc. introduced the Hudson RCI TurboMist, a compact nebulizer designed for efficient medication delivery, enhancing its product lineup

Berry Global Introduces BerryHaler for Effective Combination Drug Delivery

• April 2024: Berry Global unveiled the BerryHaler, a dual-chamber dry powder inhaler with a dose counter, aimed at facilitating combination drug delivery for patients

GE Healthcare and Masimo Collaborate to Launch SET Pulse Oximetry on Wearable Platform

• November 2023: GE Healthcare partnered with Masimo to integrate SET pulse oximetry into Masimo’s wireless, wearable Portrait Mobile platform, bolstering its international presence

Onera Health Launches Polysomnography-as-a-Service to Strengthen Presence in Europe

• September 2022: Onera Health launched a polysomnography-as-a-service offering for diagnosing sleep disorders, expanding its reach in Germany and the Netherlands

Max Ventilator Unveils Multifunctional NIV Ventilators with Integrated Oxygen Therapy

• May 2022: Max Ventilator debuted multifunctional Non-Invasive Ventilators (NIV) with built-in oxygen therapy to address rising patient needs

The global Respiratory Care Devices market can be categorized as Product, Disease Indication, End User and Region.